These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 95210)

  • 41. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function?
    Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1974; 10():83-91. PubMed ID: 4367772
    [No Abstract]   [Full Text] [Related]  

  • 42. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH; Ayestas MA; Rothman RB
    Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of chronic D-fenfluramine administration on rat hypothalamic serotonin levels and release.
    Schaechter JD; Wurtman RJ
    Life Sci; 1989; 44(4):265-71. PubMed ID: 2464733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation of serotonin metabolism by dieldrin.
    Kohli KK; Chandrasekaran VP; Venkitasubramanian TA
    J Neurochem; 1977 Jun; 28(6):1397-9. PubMed ID: 874505
    [No Abstract]   [Full Text] [Related]  

  • 45. Different effects of fenfluramine isomers and metabolites on extracellular 5-HIAA in nucleus accumbens and hippocampus of freely moving rats.
    De Simoni MG; Juraszczyk Z; Fodritto F; De Luigi A; Garattini S
    Eur J Pharmacol; 1988 Aug; 153(2-3):295-9. PubMed ID: 2460361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolactin response to fenfluramine is independent of serotonin release.
    McCann UD; Hatzidimitriou G; Ricaurte GA
    Eur J Pharmacol; 1996 Sep; 312(2):R1-2. PubMed ID: 8894606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration.
    Gardier AM; Wurtman RJ
    Brain Res; 1991 Feb; 540(1-2):325-30. PubMed ID: 1711396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonparallel changes in brain monoamines of pyridoxine-deficient growing rats.
    Dakshinamurti K; LeBlancq WD; Herchl R; Havlicek V
    Exp Brain Res; 1976 Nov; 26(4):355-66. PubMed ID: 1001386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selection.
    Kim SH; Wurtman RJ
    Physiol Behav; 1988; 42(4):319-22. PubMed ID: 2838855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The contribution of 5-hydroxyindolepyruvic acid to cerebral 5-hydroxyindole metabolism.
    Millard SA; Gál EM
    Int J Neurosci; 1971 Feb; 1(3):211-8. PubMed ID: 5161757
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD; Urban JH; Richardson KD; Bethea CL
    Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis.
    Sabol KE; Richards JB; Seiden LS
    Brain Res; 1992 Jul; 585(1-2):421-4. PubMed ID: 1511330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biosynthesis and metabolism of 5-hydroxytryptamine in the central nervous system.
    Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):3-12. PubMed ID: 128748
    [No Abstract]   [Full Text] [Related]  

  • 54. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role and control of brain 5-hydroxytryptamine.
    Curzon G
    Acta Neurol (Napoli); 1977; 32(2):121-31. PubMed ID: 201156
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fenfluramine effects on serotonergic measures in vervet monkeys.
    Brammer GL; Raleigh MJ; Ritvo ER; Geller E; McGuire MT; Yuwiler A
    Pharmacol Biochem Behav; 1991 Oct; 40(2):267-71. PubMed ID: 1687165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of tryptophan hydroxylase and content of indolamines in discrete brain regions after a long-term hypoxic exposure in the rat.
    Poncet L; Denoroy L; Dalmaz Y; Pequignot JM
    Brain Res; 1997 Aug; 765(1):122-8. PubMed ID: 9310402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism.
    Fuller RW; Baker JC; Perry KW; Molloy BB
    Neuropharmacology; 1975 Oct; 14(10):739-46. PubMed ID: 1196472
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.